|Podcasts|June 26, 2018

Exploring the Current State of Precision Medicine at the ASCO Annual Meeting

During this year's American Society of Clinical Oncology (ASCO) annual meeting, we sat down with 4 physicians to discuss their experiences with precision medicine, how it's changing oncology care, challenges associated with the shift, and where they think the future of precision medicine is headed.

As precision medicine continues to play a growing role in oncology, this year's American Society of Clinical Oncology (ASCO) annual meeting drew in more than 30,000 oncology professionals to discuss new research and practices surrounding the movement. While precision medicine comes with great promise for patient outcomes, it also comes with new and complex challenges for physicians.

During the ASCO annual meeting, we sat down with 4 physicians to discuss their experiences with precision medicine, how it's changing oncology care, challenges associated with the shift, and where they think the future of precision medicine is headed.

To listen, login to the website.


Related to this article

CAR T-cell therapy | Image: AdobeStock
In the years since the first approval for CAR T-cell therapy, major managed care plans have adopted mechanisms to include these treatments. But many employer-sponsored plans may not be required to cover them, and such treatments are "lasered out."